Grufity logo
Grufity logo
PAHC

PAHC - Phibro Animal Health Corp Stock Price, Fair Value and News

$36.38+1.14 (+3.23%)
Delayed as of 28 Jul 2026, 02:05 pm ET

67/100

PAHC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

67/100

PAHC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

PAHC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PAHC Price Action

Last 7 days

6.7%

Last 30 days

11.3%

Last 90 days

-35.0%

Trailing 12 Months

20.9%

PAHC RSI Chart

PAHC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PAHC Valuation

Market Cap

1.4B

Price/Earnings (Trailing)

13.98

Price/Sales (Trailing)

0.95

EV/EBITDA

11.11

Price/Free Cashflow

21.6

PAHC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

PAHC Fundamentals

PAHC Revenue

Revenue (TTM)

1.5B

Rev. Growth (Yr)

10.27%

Rev. Growth (Qtr)

2.58%

PAHC Earnings

Earnings (TTM)

102.2M

Earnings Growth (Yr)

15.06%

Earnings Growth (Qtr)

-4.32%

PAHC Profitability

EBT Margin

8.59%

Return on Equity

28.25%

Return on Assets

7.07%

Free Cashflow Yield

4.63%

PAHC Investor Care

Dividend Yield

1.36%

Dividend/Share (TTM)

0.48

Shares Dilution (1Y)

0.08%

Diluted EPS (TTM)

2.34

Revenue & Growth

How Phibro Animal Health Corp generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
20261.5B---
20251.2B1.3B1.4B1.5B
2024999.6M1.0B1.0B1.1B
2023978.1M977.9M976.7M982.0M
2022907.3M942.3M960.1M972.1M
2021799.0M833.4M852.8M879.4M
2020818.4M800.4M805.8M798.0M
2019835.9M828.0M817.6M813.4M
2018803.0M820.0M826.7M839.1M
2017758.6M764.3M769.7M784.0M
2016747.3M751.5M752.4M752.2M
2015747.3M748.6M748.3M751.3M
2014672.4M691.9M717.1M733.1M
2013653.4M653.2M653.3M661.9M
2012-654.1M653.9M653.6M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Phibro Animal Health Corp

PAHC
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
 CEO
 WEBSITEpahc.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers Specialty & Generic
 EMPLOYEES1920

Phibro Animal Health Corp Frequently Asked Questions

PAHC is the stock ticker symbol of Phibro Animal Health Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Jul 27 2026, market cap of Phibro Animal Health Corp is 1.43 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Mon Jul 27 2026, PAHC's PE ratio (Price to Earnings) is 13.98 and Price to Sales (PS) ratio is 0.95. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PAHC PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Phibro Animal Health Corp has provided 0.055 (multiply by 100 for percentage) rate of return.